VNT Vontier Corp

$29.91 +2.92%

Healthcare · Totalizing Fluid Meters & Counting Devices

Vontier Corp (VNT) is a healthcare company in the Totalizing Fluid Meters & Counting Devices industry, with a market capitalization of $4.2 billion. Shares last traded at $29.91, 37.8% below their 52-week high. Over the past year the stock is down 15.8%. VNT trades at a price-to-earnings ratio of 10.37, below the Healthcare median of 25.98. Net profit margin is 13.2%, above the peer median of 0.0%. Revenue grew 3.2% year over year. The shares yield 0.3% in dividends.

Market Cap

$4.2B

Shares Out

140.8M

EPS (TTM)

$4.36

P/E Ratio

6.86

P/S Ratio

1.37

P/B Ratio

3.35

Dividend / Share

$0.10

Dividend Yield

0.33%

52-Week High

$48.05

52-Week Low

$27.43

Volume

124,438

Avg Vol (3m)

111,567.397

Performance

+4.31%

+7.63%

-15.34%

-20.60%

YTD

-20.89%

-15.82%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

51.52

SMA (50)

$31.86

SMA (200)

$37.12

Price vs SMA50

-6.13%

Price vs SMA200

-19.43%

ATR (14)

$0.93

Financials

Revenue

$3.1B

Net Income

$406M

Gross Margin

46.4%

Operating Margin

18.3%

Net Margin

13.2%

Return on Equity

32.3%

Return on Assets

9.8%

Current Ratio

1.23

Debt / Equity

1.27

Revenue Growth (YoY)

+3.2%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.66	2026-05-07
FY 2025	$2.76	2026-02-12
Q3 2025	$1.90	2025-10-30
Q2 2025	$1.21	2025-07-31
Q1 2026	$0.59	2026-05-07
FY 2025	$2.75	2026-02-12

Full earnings history →

Healthcare peers

VNT vs 14 sector peers (Healthcare), by market cap.

P/E vs peers

10.37 / 25.98 med

-60% discount

P/S vs peers

1.37 / 2.59 med

-47% discount

Net margin vs peers

13.2% / 0.0% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
LIN	Linde	$236.9B	34.34	6.97	20.3%	-0.75%
AMGN	Amgen	$182.1B	23.62	4.96	21.0%	-1.27%
TMO	Thermo Fisher Scientific	$172.7B	25.70	3.88	15.1%	+0.67%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
GILD	Gilead Sciences	$153.5B	18.04	5.21	28.9%	-1.46%
ISRG	Intuitive Surgical	$144.0B	50.41	14.30	28.4%	+1.06%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
DHR	Danaher Corporation	$125.4B	34.70	5.10	14.7%	-0.38%
SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.